The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future

British Journal of Clinical Pharmacology
B N Prichard

Abstract

All beta-adrenoceptor blocking drugs that have been described share the common property of being competitive inhibitors. They differ in their associated properties, the presence or absence of cardioselectivity, membrane stabilizing activity, and partial agonist activity. Recently some beta-adrenoceptor blocking drugs have been reported which also possess alpha-adrenoceptor blocking activity. The associated properties have been used as a basis for classifying beta-adrenoceptor blocking drugs (Fitzgerald, 1969, 1972). The presence or absence of cardioselectivity is most useful for dividing beta-adrenoceptor blocking drugs. The non-selective drugs (Division I) can be further divided according to the presence or absence of intrinsic sympathomimetic activity (ISA) and membrane stabilizing activity (Fitzgerald's groups I-IV). Group I possess both membrane activity and ISA, e.g. alprenolol, oxprenolol, group II just membrane action, e.g. propanolol, group III ISA but no membrane action, e.g. pindolol. Fitzgerald placed pindolol in group I but should be placed in group III as it possesses a high degree of beta-adrenoceptor blocking potency in relation to its membrane activity (Prichard, 1974). Finally drugs in group IV have neither ISA...Continue Reading

References

Aug 1, 1976·The Journal of Allergy and Clinical Immunology·H M Guirgis, R G Townley
Sep 1, 1976·Clinical Pharmacology and Therapeutics·M GuazziF Magrini
Nov 1, 1976·The American Journal of Medicine·J V Levy
Jan 1, 1977·British Heart Journal·D A RichardsE J Knight
Nov 1, 1976·The British Journal of Ophthalmology·M J MacdonaldC I Phillips
Jan 8, 1977·British Medical Journal·J WebsterN P Barker
Aug 1, 1976·Australian and New Zealand Journal of Medicine·W A Pettinger, H C Mitchell
May 8, 1976·Lancet·L Dintenfass, R Lake
May 21, 1977·Lancet·P S SeverR D Tunbridge
May 28, 1977·Lancet
Jan 9, 1975·The New England Journal of Medicine·E L BravoH P Dustan
Jan 18, 1975·British Medical Journal·K M FoxC P Aber
Apr 1, 1975·American Heart Journal·G Lohmöller, E D Frohlich
Jan 4, 1975·The Medical Journal of Australia·R Zacest
Jan 4, 1975·The Medical Journal of Australia·P Kincaid-Smith
Feb 1, 1975·The Journal of Clinical Investigation·W A Pettinger, K Keeton
May 17, 1975·British Medical Journal·L HanssonA Westerlund
Sep 1, 1975·European Journal of Pharmacology·H L Garvey, N Ram
Oct 14, 1977·European Journal of Clinical Pharmacology·L HanssonM Holm
Nov 1, 1977·Postgraduate Medical Journal·C M CastledenC F George
Jan 1, 1977·Current Medical Research and Opinion·N K GostickN P Barmer
Apr 24, 1976·British Medical Journal·A P Douglas-Jones, J M Cruickshank
Jun 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·H Teräväinen, A Larsen
Dec 19, 1975·European Journal of Clinical Pharmacology·I Persson
Apr 1, 1975·British Journal of Clinical Pharmacology·T O MorganA E Doyle
Jan 1, 1976·European Journal of Clinical Pharmacology·R H BergstrandG Berglund
Dec 1, 1976·Clinical Science and Molecular Medicine. Supplement·R FagardA Missotten
Oct 14, 1977·European Journal of Clinical Pharmacology·E B Pedersen, H J Kornerup
Jun 1, 1976·British Journal of Clinical Pharmacology·R LancasterW S Peart
Dec 1, 1976·Archives of Ophthalmology·D H ShinB Becker
Jan 1, 1976·European Journal of Clinical Pharmacology·Y A WeissJ M Alexandre
Oct 18, 1975·British Medical Journal·J C PetrieJ A Lewis
Jan 4, 1975·The Medical Journal of Australia·J W Freeman, L W Knight
Jul 19, 1975·British Medical Journal·H J Waal-Manning, F O Simpson
Sep 1, 1975·American Heart Journal·J C DormoisA S Nies
Nov 1, 1975·British Medical Journal·P BjerleG Agert
Nov 1, 1975·Proceedings of the Society for Experimental Biology and Medicine·A DornierP Granger
Sep 25, 1971·Lancet·L HanssonH Aberg
May 6, 1972·Lancet·L J Beilin, B E Juel-Jensen
Aug 5, 1972·Lancet·P Taggart, M E Carruthers
Dec 4, 1971·Lancet·H J Waal-Manning, F O Simpson
Jun 1, 1972·European Journal of Clinical Pharmacology·W AenishänslinM Turri
Jan 20, 1973·British Medical Journal·U ThadaniS H Taylor
May 26, 1973·British Medical Journal·E B Raftery, A M Denman
Oct 1, 1973·Scandinavian Journal of Clinical and Laboratory Investigation·H H Parving, F Gyntelberg
Jan 12, 1974·British Medical Journal·G S StokesI R Thornell
Aug 1, 1973·Clinical Science and Molecular Medicine. Supplement·P Kincaid-SmithM C Laver
Jan 1, 1974·European Journal of Clinical Pharmacology·I NordenfeltS Persson
Jul 1, 1974·Clinical and Experimental Pharmacology & Physiology·M D Day, A G Roach
Nov 26, 1966·Lancet·J W Paterson, C T Dollery
Mar 9, 1968·Lancet·J A Taylor
Nov 29, 1969·Lancet·M E Carruthers
Sep 1, 1966·The American Journal of Cardiology·S A Stephen
Nov 9, 1974·British Medical Journal·R H FelixM G Dahl
Jan 1, 1971·Clinical Pharmacology and Therapeutics·J HammerE D Freis
Sep 1, 1966·The American Journal of Cardiology·D A CHAMBERLAIN
Sep 1, 1966·The American Journal of Cardiology·J P Stock
Dec 1, 1966·The Journal of Pharmacy and Pharmacology·J Maj, R Langwinski
Sep 1, 1969·The Journal of Clinical Endocrinology and Metabolism·N WinerA D Freedman
Oct 1, 1969·European Journal of Pharmacology·C Raper, J Wale
Mar 5, 1970·The New England Journal of Medicine·E GilmoreC A Chidsey
Nov 1, 1969·Acta Medica Scandinavica·C Furberg, G Michaelson
Nov 1, 1969·Acta Medica Scandinavica·G Tibblin, B Ablad
Jul 1, 1970·Clinical Pharmacology and Therapeutics·A J RiceW R WILSON
Nov 7, 1970·British Medical Journal·A W LeishmanR A Dixon
Aug 1, 1970·The Journal of Pharmacy and Pharmacology·B AbladB Waldeck
Nov 1, 1970·The Journal of Pharmacy and Pharmacology·A M Barrett, B Nunn
Mar 8, 1971·JAMA : the Journal of the American Medical Association·L J Lyon, M A Nevins
Apr 1, 1971·The American Journal of Cardiology·B N SinghD T Kelly
Dec 1, 1971·American Heart Journal·R C TaraziH P Dustan
Feb 1, 1972·The Journal of Clinical Endocrinology and Metabolism·A M Michelakis, R G McAllister
Feb 1, 1972·Circulation Research·T G PickeringP Sleight
Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser
May 1, 1972·Cardiovascular Research·L J PelidesJ P Shillingford
Aug 5, 1972·The Medical Journal of Australia·T O MorganA E Doyle
Nov 1, 1974·Postgraduate Medical Journal·L J LibmanB I Hoffbrand
Dec 14, 1974·British Medical Journal·E B Raftery
May 1, 1972·British Journal of Haematology·J F DavidsonG P McNicol
Jul 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·S JuliusR London
Aug 5, 1972·The Medical Journal of Australia·P Thorpe
Feb 9, 1974·The Medical Journal of Australia·M C LaverP Kincaid-Smith
May 11, 1974·British Medical Journal·G S Stokes, M A Weber
Mar 22, 1973·The New England Journal of Medicine·W J LouisS Anavekar
May 1, 1973·British Heart Journal·P A MajidS H Taylor
Sep 1, 1973·Atherosclerosis·P J Whittington-ColemanB H Douglas
Jun 1, 1974·British Heart Journal·P A MajidS H Taylor
Apr 1, 1968·Circulation·D W RichardsonL W Preston
Jun 8, 1968·British Medical Journal·G S Humphreys, D G Delvin
May 1, 1969·Clinical Pharmacology and Therapeutics·J D Fitzgerald
Oct 6, 1969·JAMA : the Journal of the American Medical Association·E A AmsterdamS Wolfson
Feb 21, 1970·British Medical Journal·F J Zacharias, K J Cowen
Sep 1, 1966·The American Journal of Cardiology·P M GILLAM, B N Prichard
Jun 1, 1972·American Heart Journal·F J ZachariasB G Wall
Feb 27, 1971·British Medical Journal·D J ColtartD G Shand
Dec 1, 1971·Acta Medica Scandinavica·L HanssonA Westerlund
Sep 30, 1965·The New England Journal of Medicine·J A OatesR E Lee
Sep 1, 1966·Clinical Pharmacology and Therapeutics·H J Waal
Mar 1, 1970·British Heart Journal·B N PrichardJ Hamer
Sep 1, 1970·Journal of Pharmaceutical Sciences·G J Kelliher, J P Buckley
Jan 9, 1971·British Medical Journal·A HeffernanJ Bugler
Feb 13, 1971·British Medical Journal·A EbringerM L Mashford
Mar 1, 1968·Circulation·E D FrohlichI H Page
Aug 3, 1968·British Medical Journal·S N Tewari
Jul 1, 1968·Postgraduate Medical Journal·S N Tewari, R H Grant
Nov 1, 1968·The American Journal of Cardiology·J A NicoteroA P Shapiro
Jan 4, 1969·British Medical Journal·B N Prichard, P M GILLAM
May 1, 1969·British Journal of Pharmacology·D Dunlop, R G Shanks
Mar 15, 1969·British Medical Journal·F J Zacharias
Sep 1, 1966·The American Journal of Cardiology·F A Richards
Sep 1, 1966·The American Journal of Cardiology·B N Prichard, P M GILLAM
Jul 1, 1963·Circulation·W R WILSON, R OKUN
May 9, 1964·British Medical Journal·B N Prichard
Sep 19, 1964·British Medical Journal·B N Prichard, P M GILLAM

Citations

Aug 1, 1979·Journal of Clinical Pharmacology·J E Scrazzolo, A G Queirol
Jan 1, 1983·European Journal of Clinical Pharmacology·M W Millar-CraigE B Raftery
Aug 1, 1982·American Heart Journal·R J WaldenB N Prichard
Jun 15, 1988·The American Journal of Cardiology·M R Weir, J R Sowers
May 1, 1979·European Journal of Pharmacology·J L ElghoziP Meyer
Apr 4, 1980·European Journal of Pharmacology·K SugawaraM Ozaki
Jan 1, 1981·The International Journal of Biochemistry·C G Morley, V L Royse
Jul 1, 1993·Pharmacology, Biochemistry, and Behavior·M TakitaI Muramatsu
Jan 1, 1983·Pharmacology & Therapeutics·A J Scriven, P J Lewis
May 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M ItoK Kanmatsuse
Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Sep 17, 1981·The New England Journal of Medicine·W H Frishman
Apr 21, 1983·The New England Journal of Medicine·W H Frishman
Apr 7, 2005·Clinical and Experimental Pharmacology & Physiology·Frédéric JacobJohn W Osborn
Jan 1, 1985·European Journal of Clinical Pharmacology·P A van Zwieten, P B Timmermans
Mar 29, 2014·International Journal of Hypertension·Hirofumi Tomiyama, Akira Yamashina
Jan 1, 1980·Pharmacology & Therapeutics·B N Prichard, C W Owens
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·M A van BaakJ F Smits
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·A F Aderounmu
May 15, 1987·The American Journal of Cardiology·A J Man in 't Veld
Oct 17, 1983·The American Journal of Medicine·T Baum, E J Sybertz
Nov 10, 1983·The American Journal of Cardiology·U Thadani
May 1, 1982·British Journal of Clinical Pharmacology·R C Dhatariya, A J Blowers
Dec 1, 1981·Clinical Endocrinology·S KaurI Ramsay
Mar 1, 1985·New Zealand Veterinary Journal·M A Gething
Jun 15, 1988·The American Journal of Cardiology·M R Weir, E Saunders
Dec 26, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Kinji IshikawaSecondary Prevention Group
Aug 4, 2006·Organic & Biomolecular Chemistry·Alexandra FagerströmRoland Isaksson
Sep 1, 1982·Acta Neurologica Scandinavica·T A Larsen, H Teräväinen
Jun 1, 1981·Journal of Autonomic Pharmacology·S A Doggrell, L Vincent
Jan 1, 1993·Journal of Toxicology. Clinical Toxicology·P TabouletC Bismuth
Jun 12, 1979·European Journal of Clinical Pharmacology·L A SalakoR A Adio
Jan 1, 1982·British Journal of Clinical Pharmacology·B N Prichard, R J Walden
Apr 1, 1979·British Journal of Clinical Pharmacology·B N Prichard, D A Richards
Apr 1, 1979·British Journal of Clinical Pharmacology·B N Prichard, D A Richards

Related Concepts

Adrenergic beta-Antagonists
Diastolic Blood Pressure
Cardiac Output
Drug Combinations
Hypertensive Disease
Neurons
Blood Plasma Volume
Pressoreceptors
Preprorenin
Valsalva Maneuver

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.